Symposium: (World Allergy Congress)

Sunday, 4 December 2011

Sunday | Monday | Tuesday | Wednesday | top

12:30 - 14:00

Poster Symposium 1: Allied Health

Coral Gallery 3 (Fiesta Americana)

Chairpersons: Connie Katelaris (Australia) , Dennis Ledford (US) and Birthe Dahl (Denmark)

12:30 - 13:15

Poster Viewing

13:15 - 00:00

1000: Reduction In Allergic Rhinitis Index by Decreasing Aero-Allergens and Malodor Causing Volatile Organic Compounds by Luna Air Purifiers Using Photo-Catalytic Oxidation (PCO) Technology | Nabarun Ghosh (US)

13:15 - 00:00

1001: The Missing Link!! Specialist Nurse-Led Education for Parents of Children with Atopic Eczema | Deryn Thompson (Australia)

13:15 - 00:00

1002: Sublingual Immunotherapy for Grass Pollen Allergy In Children: A Systematic Review and Meta-Analysis | Rebecca Bryson (United Kingdom)

13:15 - 00:00

1003: Effect of EPA-DHA Supplementation on Forced Expiratory Volume in One Second (FEV1) and Triglycerides in Obese Adolescents with Hypertriglyceridemia | Nancy Mendez Berreondo (Mexico)

13:15 - 00:00

1004: A Pilot Study of Caregiver's Recall of Their Child's Skin Test Results and Environmental Remediation Education | Kristen Townsend (US)

13:15 - 00:00

1005: Evaluation and Comparison of Lung Function by Plethysmography In Adolescents with Morbid Obesity, Not Morbid Obesity and Healthy Eutrophic Children | Luis Octavio Hernandez-Mondragon (Mexico)

13:15 - 00:00

1006: Delivering An Educational Model for Allergy Immunotherapy | Claire Murphy (US)

13:15 - 00:00

1007: Selecting Primal Therapy Appropriate for the Type of Pollinosis – TOPIC-J Study | Kimihiro Okubo (Japan)

13:15 - 00:00

1008: Olfactory Disfunctions in Patients with Chronic Rhinosinusitis | María Victoria Sánchez Vallecillo (Argentina)

13:15 - 00:00

1009: Perceptions of Caregivers of Patients with Cow's Milk Allergy Regarding the Treatment Antônio Carlos Pastorino (Brazil)

13:15 - 00:00

1010: Incidence of Systemic Reactions (SRs) to Prick (P) and Intradermal (ID) Tests, Response to Immediate (“Stat”) Epinephrine IM (epi IM) Dose Vs. BMI, Number of Delayed SRs, and WAO Systemic Reaction Grade | Dona Shearer (US)

13:15 - 00:00

1011: The “Allergy Blog” and Laypersons Questions: An Interactive Educational Experience | Jose Luiz Rios (Brazil)

13:15 - 00:00

1012: Anaphylaxis After Anesthetic Reversal | Sendy Chugo (Spain)

13:15 - 00:00

1013: Establishment of Reference Values for Differential Cell Counts in Nasal Lavage of Healthy Young Adults Jing Li (China)

Monday, 5 December 2011

Sunday | Monday | Tuesday | Wednesday | top

12:45 - 14:15

Poster Symposium 2: Asthma Treatment

Bacalar (Cancún Center)

Chairpersons: Michael Schatz (US) and Paul O'Byrne (Canada)

12:45 - 13:30

Poster Viewing

13:30 - 00:00

2143: Reduction in Asthma Deteriorations in Subjects with Persistent Asthma Not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids: A Pooled Analysis From Three Clinical Trials Using Combined Mometasone Furoate/Formoterol | Steven Weinstein (US)

13:30 - 00:00

2144: Efficacy Comparison of Mometasone Furoate/Formoterol Versus Fluticasone Propionate/Salmeterol Combination Therapies in Subjects with Persistent Asthma: Noninferiority and Onset-of-Action Findings Hendrik Nolte (US)

13:30 - 00:00

2145: Efficacy and Safety of Two Doses of Mometasone Furoate/Formoterol Combination Treatment in Subjects with Severe Asthma | Steven Weinstein (US)

13:30 - 00:00

2146: Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects with Persistent Asthma Hendrik Nolte (US)

13:30 - 00:00

2147: Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol Hendrik Nolte (US)

13:30 - 00:00

2148: Efficacy and Safety of Combined Mometasone Furoate/Formoterol 100/10ìg Twice Daily in Subjects with Asthma Inadequately Controlled on Low-Dose Inhaled Corticosteroids | Eli Meltzer (US)

13:30 - 00:00

2149: Prevalence of Swallowing Dysfunction in Severe Asthma: Preliminary Results Adelmir Souza-Machado (Brazil)

13:30 - 00:00

2150: Small Airway Function Is Consistently Improved in Asthma Patients Treated with Mometasone Furoate Delivered by a Dry Powder Inhaler Ariel Teper (US)

13:30 - 00:00

2151: Influence of Montelukast on the State of Eosinophil Activation in Asthmatic Children | Valéria Botan (Brazil)

13:30 - 00:00

2152: The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma | Norifumi Ogawa (Japan)

13:30 - 00:00

2153: Effectiveness of Montelukast In 60 Cuban Patients with Moderate and Severe Asthma and Rhinitis | Mirta Alvarez (Cuba)

13:30 - 00:00

2154: Effect of the Treatment with Montelukast In Asthmatic Patient | Roberto O. Aguila de la Coba (Cuba)

13:30 - 00:00

2155: The Effectiveness of Two Different Methods of Salbutamol Nebulization in Children with Asthma | Andrzej Emeryk (Poland)

Tuesday, 6 December 2011

Sunday | Monday | Tuesday | Wednesday | top

12:45 - 14:15

Poster Symposium 3: Allergic Rhinitis

Bacalar (Cancún Center)

Chairpersons: Glenis Scadding (United Kingdom) and Michael A. Kaliner (US)

12:45 - 13:30

Poster Viewing

13:30 - 00:00

3148: Allergen Sensitization In Children with Allergic Rhinitis and Asthma In Guatemala | Ann Michelle Rigalt (Guatemala)

13:30 - 00:00

3149: The Impact of Breast-Feeding Duration and Mode of Delivery on Allergic Rhinitis in Korean Children: Cohort of Allergic Rhinitis in Korea (COAR-Korea) Study | Doo Hee Han (South Korea)

13:30 - 00:00

3150: The Efficacy of a Nasal Corticosteroid Ciclesonide for the Treatment of Serous Otitis Media In Atopic Children | Safa Nsouli (US)

13:30 - 00:00

3151: A Study Evaluating the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol In the Relief of Nasal Symptoms of Seasonal Allergic Rhinitis Shailesh Desai (US)

13:30 - 00:00

3152: Combination of a Nasal Antihistamine Olopatadine and a Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients Not Currently Controlled On Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist | Safa Nsouli (US)

13:30 - 00:00

3153: Desloratadine Is Safe and Well Tolerated in Adults ³55 Years Old Gokul Gopalan (US)

13:30 - 00:00

3154: Augmentation of CXCL10 Expression in Nasal Fibroblasts Derived From Patients with Recalcitrant Chronic Rhinosinusitis Associated with Bronchial Asthma | Mamoru Yoshikawa (Japan)

13:30 - 00:00

3155: Correlation Between Cu/Zn-SOD and Macrophages or MUC5AC in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps | Noritsgu Ono (Japan)

13:30 - 00:00

3156: Relationship Between Allergic Rhinitis and Dental-Facial Abnormalities | Miguel Alejandro Medina (Mexico)

Wednesday, 7 December 2011

Sunday | Monday | Tuesday | Wednesday | top

12:45 - 14:15

Poster Symposium 4: Immunotherapy

Bacalar (Cancún Center)

Chairpersons: Harold Nelson (US) and Stephen Durham (United Kingdom)

12:45 - 13:30

Poster Viewing

13:30 - 00:00

4146: AAAAI Survey On Immunotherapy Practice Patterns Concerning Dosing, Dose-Adjustment After Missed Doses and Duration of Immunotherapy | Désirée Larenas Linnemann (Mexico)

13:30 - 00:00

4147: Development of A National Guideline On Skin Testing and Immunotherapy | Désirée Larenas Linnemann (Mexico)

13:30 - 00:00

4148: Efficacy of Mite Sublingual Immunotherapy In 130 Children with Atopic Dermatitis | Jianping Tang (China)

13:30 - 00:00

4149: Down Regulation of Allergic Inflammation with Allergy Vaccine Timpol In A Murine Model of Asthma | Igor Shilovskiy (Russia)

13:30 - 00:00

4150: Clinical Efficacy and Mucosal/Systemic Antibody Response Changes After Sublingual Immunotherapy in Mite-Allergic Children: A Randomized Double-Blind, Placebo-Controlled Study in Brazil Ernesto Taketomi (Brazil)

13:30 - 00:00

4151: Treatment Satisfaction with Sublingual Immunotherapy in a Real-Life Setting | Meike Hadler (Germany)

13:30 - 00:00

4152: Long Term Follow-up After Completion of Inhalant Allergen-Specific Subcutaneous Immunotherapy Jacquelynne Corey (US)

13:30 - 00:00

4153: Long-Term Clinical Efficacy of Immunotherapy in Rhino-Conjunctivitis with Pollen Extract | Carlos Nunes (Portugal)

13:30 - 00:00

4154: IgE/IgG4 Ratio As a Possible Surrogate Marker of Clinical Efficacy During Allergen-Specific Immunotherapy with House Dust Mite Vaccines | Alexis Labrada (Cuba)

13:30 - 00:00

4155: Allergy Training and Immunotherapy in Latin America: How Survey-results lead to a Regional Overview | R Maximiliano Gomez (Argentina)

13:30 - 00:00

4156: Clinical Effects of Immunotherapy in Patients with Allergic Disease in the National Institute of Respiratory Diseases | Ma del Rosario Gonzalez Galarza (Mexico)

13:30 - 00:00

4157: Approach of Paediatric Allergists to Allergen Immunotherapy in Severe Persistent Allergic Rhinitis | Alessandro Fiocchi (Italy)

13:30 - 00:00

4158: Compliance and Persistence to Grass Immunotherapy Treatment Is Comparable for Allergy Immunotherapy Tablets and Subcutaneous Immunotherapy: A Swedish Registry Study Simon Lawton (Denmark)